Peter G. Schultz

Peter G.
Schultz is the founder of Symyx Technologies, Inc. (founded 1996), Achaogen, Inc. (founded 2002), Ambrx, Inc. (founded 2003), Ardelyx, Inc. (founded 2007), and Wildcat Discovery Technologies, Inc. (founded 2006) where Dr. Schultz holds the title of Director.
Dr. Schultz is also the founder of Phenomix Corp.,Syrrx, Inc.,Kalypsys, Inc...- Current jobs include Scientist at Affymax Research Institute, Professor at The Scripps Research Institute, Member of the National Academy of Sciences since 1993, and Member of the National Academy of Medicine (United States) since 1998.
Former jobs include Director at Nanosphere, Inc., Director at The Assay Depot, Inc., Institute Director at Novartis Institute for Functional Genomics, Inc. from 1999 to 2010, Director at Synchronicity Pharma, Inc., Investigator at Howard Hughes Medical Institute, Inc., Professor at the University of California, Berkeley from 1985 to 1998, Advisor at Presidio Partners, and Professor & Principal Investigator at Lawrence Berkeley National Laboratory.
Education includes a doctorate degree conferred in 1984 and an undergraduate degree conferred in 1979, both from California Institute of Technology.